AxoGen, Inc.

Healthcare

NASDAQ:AXGN · NASDAQ Capital Market

Market Cap $2.29B Beta 1.12 P/E (TTM) -70.5

$43.00 +1.51%

+$0.64 today

52W Low $9.22High $45.83

Vol 1.34M · Avg 1.04M

EPS (TTM)-$0.61

Medical - Devices

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+341.03%

Period High

$43.74

Period Low

$9.29

Latest

$43.00

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Taysha Gene Therapies, Inc.

NASDAQ:TSHA

$1.64B

Integra LifeSciences Holdings Corporation

NASDAQ:IART

$1.38B

AdaptHealth Corp.

NASDAQ:AHCO

$1.38B

IRadimed Corporation

NASDAQ:IRMD

$1.20B

Tandem Diabetes Care, Inc.

NASDAQ:TNDM

$1.14B

OPKO Health, Inc.

NASDAQ:OPK

$1.07B

InMode Ltd.

NASDAQ:INMD

$817.88M

Sana Biotechnology, Inc.

NASDAQ:SANA

$745.82M

Claritev Corporation

NYSE:CTEV

$526.61M

LifeMD, Inc.

NASDAQ:LFMD

$227.30M

What is the latest AXGN filing?

The latest filing shown is 4 dated May 12, 2026.

How many recent filings does AXGN have?

Intrinsic Alpha currently shows 20 recent filings for AXGN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.